Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1
- PMID: 16253240
- DOI: 10.1016/j.febslet.2005.10.010
Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1
Abstract
The modification of homeodomain-interacting protein kinase 2 (HIPK2) by small ubiquitin-like modifier 1 (SUMO-1) plays an important role in its targeting into the promyelocytic leukemia body, as well as in its differential interaction with binding partner, but the desumoylation of HIPK2 by SUMO-specific proteases is largely unknown. In this study, we show that HIPK2 is a desumoylation target for the SUMO-specific protease SENP1 that shuttles between the cytoplasm and the nucleus. Mutation analyses reveal that SENP1 contains the nuclear export sequence (NES) within the extreme carboxyl-terminal region, and SENP1 is exported to the cytoplasm in a NES-dependent manner. Sumoylated HIPK2 are deconjugated by SENP1 both in vitro and in cultured cells, and the desumoylation is enhanced either by the forced translocation of SENP1 into the nucleus or by the SENP1 NES mutant. Concomitantly, desumoylation induces dissociation of HIPK2 from nuclear bodies. These results demonstrate that HIPK2 is a target for SENP1 desumoylation, and suggest that the desumoylation of HIPK2 may be regulated by the cytoplasmic-nuclear shuttling of SENP1.
Similar articles
-
SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis.Cell Death Differ. 2008 Apr;15(4):739-50. doi: 10.1038/sj.cdd.4402303. Epub 2008 Jan 25. Cell Death Differ. 2008. PMID: 18219322
-
Control of nuclear HIPK2 localization and function by a SUMO interaction motif.Biochim Biophys Acta. 2011 Feb;1813(2):283-97. doi: 10.1016/j.bbamcr.2010.11.022. Epub 2010 Dec 8. Biochim Biophys Acta. 2011. PMID: 21145359
-
The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.Biochem Biophys Res Commun. 2008 Jul 11;371(4):823-8. doi: 10.1016/j.bbrc.2008.04.179. Epub 2008 May 12. Biochem Biophys Res Commun. 2008. PMID: 18474224
-
Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.Eur J Med Chem. 2022 Nov 5;241:114650. doi: 10.1016/j.ejmech.2022.114650. Epub 2022 Aug 1. Eur J Med Chem. 2022. PMID: 35939992 Review.
-
Role of desumoylation in the development of prostate cancer.Neoplasia. 2006 Aug;8(8):667-76. doi: 10.1593/neo.06445. Neoplasia. 2006. PMID: 16925949 Free PMC article. Review.
Cited by
-
SUMO: From Bench to Bedside.Physiol Rev. 2020 Oct 1;100(4):1599-1619. doi: 10.1152/physrev.00025.2019. Physiol Rev. 2020. PMID: 32666886 Free PMC article. Review.
-
SUMO rules: regulatory concepts and their implication in neurologic functions.Neuromolecular Med. 2013 Dec;15(4):639-60. doi: 10.1007/s12017-013-8258-6. Epub 2013 Aug 30. Neuromolecular Med. 2013. PMID: 23990202 Review.
-
Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts.Aging Cell. 2008 Oct;7(5):609-21. doi: 10.1111/j.1474-9726.2008.00411.x. Epub 2008 Jul 24. Aging Cell. 2008. PMID: 18616636 Free PMC article.
-
HIPK2 modification code for cell death and survival.Mol Cell Oncol. 2014 Oct 29;1(2):e955999. doi: 10.1080/23723548.2014.955999. eCollection 2014 Apr-Jun. Mol Cell Oncol. 2014. PMID: 27308327 Free PMC article. Review.
-
Distribution and paralogue specificity of mammalian deSUMOylating enzymes.Biochem J. 2010 Sep 1;430(2):335-44. doi: 10.1042/BJ20100504. Biochem J. 2010. PMID: 20590526 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases